Overview - Arkham 的创始人兼 CEO Miguel 在 EthCC 上发表了关于如何使用 AI 驱动的工具（如 Arkham）从链上交易的噪音中发现 Alpha 的演讲 [1] AI and On-Chain Trading - 讨论了如何使用像 Arkham 这样的人工智能工具来发现链上交易的优势 [1]

Grok 4 just set the bar now the smartest AI model in the world.https://t.co/BgNNqI7yJw ...

Core Viewpoint - NuScale Power's stock experienced significant volatility, initially dipping over 7% in early 2025 after a remarkable 445% gain in 2024, but rebounded to a 120.6% increase by June 2025, largely driven by President Trump's support for the nuclear energy sector [1][2][4]. Group 1: Government Support and Regulatory Changes - President Trump's executive orders issued on May 23 aimed to modernize the nuclear energy industry, expediting the licensing process for new reactors and reducing testing times for advanced reactors, which is crucial for NuScale Power's commercial deployment of its SMR NuScale Power Module [4][5]. - The executive orders also directed the Department of Energy to classify AI data centers as "critical defense facilities," allowing for expedited approval and deployment of advanced reactors to power these facilities, presenting significant opportunities for NuScale Power [6]. Group 2: Market Interest and Investor Sentiment - NuScale Power's CEO, John Hopkins, indicated that the company is in discussions with several "tier 1" hyperscalers interested in purchasing power, which has further fueled investor excitement [8]. - Despite the stock's impressive performance, there are expectations of potential pullbacks due to the inherent volatility associated with growth stocks like NuScale Power, especially as the company is not yet profitable [9].

Elon Musk claims Grok 4 is smarter than a human with a PhD, it just lacks "common sense."Catch up on the debut of xAI's newest model, which is releasing amid continued controversies around its predecessor: https://t.co/6sNBQKtNh1 https://t.co/CrdrPtNj0r ...

>> “BLOOMBERG TECH” IS LIVE FROM COAST-TO-COAST. WITH CAROLINE HYDE IN NEW YORK AND ED LUDLOW IN SAN FRANCISCO. ED: BLOOMBERG -- ROMAINE: NVIDIA CEO MEETING WITH U.S. PRESIDENT TRUMP AT THE WHITE HOUSE YESTERDAY.THAT IS OUT OF A BIG TRIP PLANNED NEXT WEEK TO CHINA. WE ARE LOOKING AT TESLA, WANTS TO BRING DRIVERLESS TAXES TO CALIFORNIA AND ARIZONA, AFTER LAST MONTH'S ROLLOUT IN AUSTIN, TEXAS. CRYPTO WEEK IS UPON US.WE WILL DISCUSS WHAT TO EXPECT FROM CRYPTO FOCUSED BILLS IN WASHINGTON WITH THE HEAD OF THE BL ...

xAI, Elon Musk’s artificial intelligence and social media company, is in the early stages of a funding round that could value the business at $200 billion, the FT reports https://t.co/7JMIW2SNGQ ...

Core Insights - Meta Platforms is increasingly relying on artificial intelligence to enhance its advertising business, which generated approximately $166 billion in revenue over the last 12 months, with a growth rate of 22% in 2024 compared to 16% in 2023 [2][3]. Group 1: AI and Advertising - Meta aims to allow users to fully automate ad creation and targeting using AI by the end of 2026, which could significantly streamline the ad campaign process [3][4]. - The costs associated with traditional ad campaigns can be high, with estimates indicating that basic video ads cost around $3,500 per minute and full-fledged campaigns for medium-sized businesses range from $10,000 to $20,000 per month [5][6]. - By utilizing Meta's AI tools, these costs could be dramatically reduced, making it more attractive for smaller businesses to shift their ad spending towards Meta [6][7]. Group 2: Competitive Advantage - Meta's AI advancements are expected to enhance the efficiency of ad campaigns, leading to increased revenue growth and improved margins, which are crucial for boosting the company's stock price [7][11]. - Meta ads have achieved an average return on ad spending (ROAS) of six-to-one, outperforming Google Ads, which has a four-to-one ROAS [9]. - In the U.S., Meta has the highest average revenue per user (ARPU) among social media platforms, with Instagram and Facebook generating around $223 and $191 per user, respectively, indicating strong advertiser value [10]. Group 3: Market Outlook - Analysts have a 12-month stock price forecast for Meta at $729.38, suggesting a potential upside of 1.65% from the current price of $717.51 [8]. - Despite a Moderate Buy rating, some top analysts believe there are better investment opportunities available compared to Meta [12].

It's been a banner week for the tech space. The sector hitting all-time highs again today as Nvidia pushes even further above its record $4 trillion market cap. Joining me now to discuss, Intelligent Alpha founder and CEO Doug Clinton.Doug, good to see you. Um, I mean, obviously that's a that's a a landmark. It's obviously representative of of just the sheer massive economics that are flowing in Nvidia's direction.Uh, but I wonder kind of weigh in on what we were just talking about with the prior panel, whi ...

The carrier aims to use Fetcherr, an Israeli AI tool, on 20% of domestic flights by the end of the year, President Glen Hauenstein said. https://t.co/9tdeofs2wR ...

Company Overview - Profusa, Inc. is a commercial stage digital health company based in Berkeley, California, focused on developing tissue-integrated sensors for continuous monitoring of biochemistry [4] - The company aims to provide affordable, long-lasting, injectable biosensors that transmit actionable medical-grade data for personal and medical use [4] Business Combination - Profusa announced the closing of its business combination with NorthView Acquisition Corp. (NVAC), which was approved by NVAC's shareholders on June 9, 2025 [1] - The combined company will operate under the name Profusa, Inc., with common stock expected to begin trading on Nasdaq under the ticker symbol "PFSA" starting July 14, 2025 [1] - A secured convertible promissory note was issued to an institutional investor, raising $9 million to cover transaction costs and support future working capital needs, with a total of up to $20 million available under the convertible note facility [2] Technology and Vision - Profusa's technology platform is designed to continuously monitor and transmit body chemistries to smartphone applications, leveraging advanced data analytics and AI technologies [2] - The company aims to improve health management for chronic diseases such as diabetes, critical limb ischemia (CLI), and peripheral arterial disease (PAD) [2] Leadership and Support - The company is led by a visionary scientific team and an experienced management group, supported by dedicated employees, partners, and investors [2]